The molecular blueprint of targeted radionuclide therapy
(opens in new window)
Author(s):
Irina Primac, Kevin Tabury, Alpaslan Tasdogan, Sarah Baatout, Ken Herrmann
Published in:
Nature Reviews Clinical Oncology, Issue 22, 2025, ISSN 1759-4774
Publisher:
Springer Science and Business Media LLC
DOI:
10.1038/S41571-025-01069-Z
Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [18F]FDG in gynaecological malignancies: systematic literature review and meta-analysis
(opens in new window)
Author(s):
Anita Florit, Elizabeth J. de Koster, Serena Sassano, Lejla Alic, Giusi Pisano, Floris H. P. van Velden, Salvatore Annunziata, Irina Primac, Maria Rosaria Ruggiero, Cristina Müller, Evis Sala, Wolfgang P. Fendler, Giovanni Scambia, Lioe-Fee de Geus-Oei, Anna Fagotti, Vittoria Rufini, Angela Collarino
Published in:
European Journal of Nuclear Medicine and Molecular Imaging, Issue 52, 2025, ISSN 1619-7070
Publisher:
Springer Science and Business Media LLC
DOI:
10.1007/S00259-025-07277-0